Preliminary experiments indicate conolidine may well inhibit unique ion channels, minimizing neuronal excitability and limiting agony alerts. This mechanism is particularly appropriate in neuropathic discomfort, exactly where irregular signaling results in persistent pain. Also, conolidine seems to impact G protein-coupled receptor (GPCR) pathways